Guardant Health (GH) Other Accumulated Expenses (2023 - 2024)

Guardant Health's (GH) quarterly Other Accumulated Expenses came in at $68.3 million in Q4 2024, up 7.67% year-on-year from $63.5 million in Q1 2024, and up 7.67% quarter-over-quarter from $63.5 million in Q4 2023.

Guardant Health (GH) Other Accumulated Expenses (2023 - 2024) Analysis & Trends

Guardant Health has disclosed Other Accumulated Expenses across 2 years of filings, most recently posting $68.3 million for Q4 2024.

  • Other Accumulated Expenses for Q4 2024 came in at $68.3 million, up 7.67% year-over-year; the trailing twelve-month figure through Dec 2024 was $68.3 million (up 7.67% YoY), and the FY2024 annual result was $68.3 million, up 7.67% from the prior year.
  • Other Accumulated Expenses came in at $68.3 million for Q4 2024 at Guardant Health, up from $63.5 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $68.3 million in Q4 2024 to a low of $63.5 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 Guardant Health 17.09 Bn 15.99 Bn 196.75 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 68.35 Mn
Dec 31, 2023 63.48 Mn